Skip to content

Clinical trials

Completed Hepatitis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Status: Completed Country / region: Canada Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20063
20071
20091
20101
20114
20123
20132
20151
20161
20171
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences7
Dynavax Technologies Corporation2
GlaxoSmithKline2
Human Genome Sciences Inc.2
AbbVie1
Centre hospitalier de l'Université de Montréal (CHUM)1
F-star Therapeutics, Inc.1
Janssen R&D Ireland1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis22
Hepatitis B10
Hepatitis B, Chronic6
Hepatitis C6
Hepatitis C, Chronic4
Hepatitis, Chronic3
Liver Diseases2
Acquired Immunodeficiency Syndrome1
Fibrosis1
Infections1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.